background image

Paid Clinical Trials Great Falls

Discover 94 paid clinical trials in Great Falls, Montana. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)

for
Myelodysplastic Syndrome
Location: Great Falls MT, Anaconda MT, Missoula MT, Kalispell MT,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06577441

Phase2, Recruiting

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

for
Acute Myeloid Leukemia
Location: Great Falls MT, Anaconda MT, Missoula MT, Kalispell MT,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06672146

Phase2, Recruiting

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

for
Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8,
Location: Great Falls MT, Anaconda MT, Missoula MT, Kalispell MT,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06498635

Phase3, Recruiting

Multi-Institutional Registry for Prostate Cancer Radiosurgery

for
Prostate Cancer Early Risk Treated by Radiosurgery,
Location: Great Falls MT, Missoula MT, Billings MT,
Sponsor: RPCR, Inc.

Sex: Male

Age: 18 - 70+

Code: NCT01226004

Recruiting

Evaluating SUI-100™, A Non-Invasive Device for the Treatment of Stress Urinary Incontinence

for
Stress Urinary Incontinence (SUI)
Location: Great Falls MT, Boise ID, Las Vegas NV, Phoenix AZ,
Sponsor: Acoustic Wave Cell Therapy, Inc.

Sex: Female

Age: 22 - 70+

Code: NCT06862648

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Anti-Lag-3 (Relatlimab) and Anti-PD-1 Blockade (Nivolumab) Versus Standard of Care (Lomustine) for the Treatment of Patients With Recurrent Glioblastoma

for
Progressive Glioblastoma, Recurrent Glioblastoma
Location: Great Falls MT, Anaconda MT, Bozeman MT, Missoula MT,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06325683

Phase2, Recruiting

Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma

for
Endometrial Adenocarcinoma,
Location: Great Falls MT, Anaconda MT, Bozeman MT, Missoula MT,
Sponsor: National Cancer Institute (NCI)

Sex: Female

Age: 18+

Code: NCT05112601

Phase2, Recruiting

Testing the Addition of AZD6738 (Ceralasertib) to Immunotherapy to Increase Time Without Cancer for Patients With Non-Small Cell Lung Cancer

for
Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8,
Location: Great Falls MT, Missoula MT, Billings MT, Sandpoint ID,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06732401

Phase3, Recruiting

Comparing Radiation Therapy to Usual Care for Patients With High-Risk Bone Asymptomatic Metastases, PREEMPT Trial

for
Metastatic Malignant Neoplasm in the Bone,
Location: Great Falls MT, Havre MT, Bozeman MT, Missoula MT,
Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT06745024

Phase3, Recruiting

Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy

for
Recurrent Non-Muscle Invasive Bladder Carcinoma,
Location: Great Falls MT, Havre MT, Anaconda MT, Bozeman MT,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT07000084

Phase3, Recruiting